4//SEC Filing
WORLAND STEPHEN T 4
Accession 0001209191-22-029890
CIK 0001828522other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 8:44 PM ET
Size
6.0 KB
Accession
0001209191-22-029890
Insider Transaction Report
Form 4
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
- Award
Common Stock
2022-05-13$1.53/sh+1,837$2,811→ 194,978 total
Holdings
- 562,339(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
- [F2]The Form 4 previously filed on behalf of the Reporting Person on August 27, 2021 inadvertently overstated the number of shares held directly following the transactions reported therein. This reflects the correct number of shares directly and indirectly held by the Reporting person following the previously reported transactions and the transaction reported herein.
Documents
Issuer
eFFECTOR Therapeutics, Inc.
CIK 0001828522
Entity typeother
Related Parties
1- filerCIK 0001283307
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 8:44 PM ET
- Size
- 6.0 KB